VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
PDEXPro-Dex, Inc.
$64.40$206M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

PDEX logoPro-Dex, Inc.(PDEX)Earnings, Financials & Key Ratios

PDEX•NASDAQ
24.1× P/E·Price updated Jun 19, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustrySurgical and interventional devices
AboutPro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.Show more
  • Revenue$67M+23.7%
  • EBITDA$12M+43.1%
  • Net Income$9M+322.1%
  • EPS (Diluted)2.67+345.0%
  • Gross Margin29.3%+8.4%
  • EBITDA Margin17.91%+15.7%
  • Operating Margin16.05%+20.5%
  • Net Margin13.48%+241.3%
  • ROE26.6%+290.6%

PDEX Key Insights

Pro-Dex, Inc. (PDEX) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 91 (top 9%)
  • ✓Strong 5Y sales CAGR of 13.8%
  • ✓Good 3Y average ROE of 19.4%
  • ✓Share count reduced 5.9% through buybacks
  • ✓Healthy 5Y average net margin of 10.9%
  • ✓Efficient asset utilization: 1.1x turnover

✗Weaknesses

  • ✗Negative free cash flow

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when PDEX posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

PDEX Price & Volume

Pro-Dex, Inc. (PDEX) stock price & volume — 10-year historical chart

Loading chart...

PDEX Growth Metrics

Pro-Dex, Inc. (PDEX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years17.41%
5 Years13.84%
3 Years16.57%
TTM16.39%

Profit CAGR

10 Years-
5 Years7.99%
3 Years25.23%
TTM28.11%

EPS CAGR

10 Years-
5 Years12.22%
3 Years30.19%
TTM29.29%

Return on Capital

10 Years18.75%
5 Years17.29%
3 Years18.93%
Last Year24.82%

PDEX Recent Earnings

Pro-Dex, Inc. (PDEX) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 10/12 qtrs (83%)
Q2 2026Latest
Apr 30, 2026
Metric
Actual
Est
EPS
$1.20+93.5%
$0.62
Rev
$20M+11.4%
$18M
Q1 2026
Jan 29, 2026
Metric
Actual
Est
EPS
$0.66+11.9%
$0.59
Rev
$19M+7.9%
$17M
Q4 2025
Oct 30, 2025
Metric
Actual
Est
EPS
$0.62+24.0%
$0.50
Rev
$19M+21.1%
$15M
Q4 2025
Sep 4, 2025
Metric
Actual
Est
EPS
$0.36-23.4%
$0.47
Rev
$17M+14.3%
$15M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 30, 2026
$1.20vs $0.62+93.5%
$20Mvs $18M+11.4%
Q1 2026Jan 29, 2026
$0.66vs $0.59+11.9%
$19Mvs $17M+7.9%
Q4 2025Oct 30, 2025
$0.62vs $0.50+24.0%
$19Mvs $15M+21.1%
Q4 2025Sep 4, 2025
$0.36vs $0.47-23.4%
$17Mvs $15M+14.3%
Based on last 12 quarters of dataView full earnings history →

PDEX Peer Comparison

Pro-Dex, Inc. (PDEX) competitors in Surgical and interventional devices — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
NSYS logoNSYSNortech Systems IncorporatedDirect Competitor48.73M17.49-37.21-8.04%-2.25%-7.88%0.53
LIQT logoLIQTLiqTech International, Inc.Direct Competitor8.95M0.90-1.0113.03%-55.45%-79.65%1.67
ATRC logoATRCAtriCure, Inc.Product Competitor1.46B28.80-12014.88%-0.83%-0.95%0.18
MMSI logoMMSIMerit Medical Systems, Inc.Product Competitor4.01B67.2231.5611.66%9.03%8.95%0.57
NVCR logoNVCRNovoCure LimitedProduct Competitor1.62B14.28-11.708.28%-25.66%-50.82%0.85
OSIS logoOSISOSI Systems, Inc.Product Competitor3.67B222.7825.5811.33%8.42%16.74%0.72
SYK logoSYKStryker CorporationSupply Chain117.88B307.8036.6411.16%12.92%15.04%0.66
ZBH logoZBHZimmer Biomet Holdings, Inc.Supply Chain17.22B87.9724.787.2%9.05%5.77%0.59

Compare PDEX vs Peers

Pro-Dex, Inc. (PDEX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NSYS

Most directly comparable listed peer for PDEX.

Scale Benchmark

vs ABT

Larger-name benchmark to compare PDEX against a more recognizable public peer.

Peer Set

Compare Top 5

vs NSYS, LIQT, ATRC, MMSI

PDEX Income Statement

Pro-Dex, Inc. (PDEX) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Sales/Revenue
21.94M22.46M27.17M34.83M42.04M42.04M46.09M53.84M66.59M74.64M
Revenue Growth %
8.86%2.38%20.95%28.2%20.69%0%9.62%16.83%23.68%16.39%
Cost of Goods Sold
14.76M14.52M17.39M21.69M28.91M28.91M33.34M39.29M47.08M53.9M
COGS % of Revenue
67.25%64.64%64.01%62.27%68.76%68.76%72.34%72.98%70.7%-
Gross Profit
7.19M▲ 0%
7.94M▲ 10.5%
9.78M▲ 23.1%
13.14M▲ 34.4%
13.13M▼ 0.1%
13.13M▲ 0.0%
12.75M▼ 2.9%
14.55M▲ 14.1%
19.51M▲ 34.1%
20.73M▲ 0%
Gross Margin %
32.75%35.36%35.99%37.73%31.24%31.24%27.66%27.02%29.3%27.78%
Gross Profit Growth %
33%10.53%23.13%34.38%-0.08%0%-2.92%14.13%34.08%-
Operating Expenses
4.34M4.54M4.79M6.08M8.01M8.01M6.99M7.38M8.82M9.93M
OpEx % of Revenue
19.77%20.2%17.62%17.46%19.05%19.05%15.16%13.7%13.25%-
Selling, General & Admin
3.11M2.65M2.91M3.77M4.99M4.99M4.18M4.19M5.18M6.69M
SG&A % of Revenue
14.19%11.77%10.7%10.81%11.88%11.88%9.08%7.78%7.79%-
Research & Development
1.23M1.89M1.88M2.31M2.98M2.98M2.8M3.19M3.64M3.23M
R&D % of Revenue
5.58%8.43%6.93%6.65%7.09%7.09%6.08%5.92%5.46%-
Other Operating Expenses
0045K035K35K0000
Operating Income
2.73M▲ 0%
2.39M▼ 12.5%
5M▲ 108.9%
7.07M▲ 41.4%
5.12M▼ 27.5%
5.12M▲ 0.0%
5.76M▲ 12.5%
7.17M▲ 24.5%
10.69M▲ 49.0%
10.81M▲ 0%
Operating Margin %
12.46%10.65%18.39%20.28%12.19%12.19%12.5%13.32%16.05%14.48%
Operating Income Growth %
419.77%-12.51%108.95%41.38%-27.5%0%12.47%24.49%49.02%-
EBITDA
3.29M2.95M5.44M7.68M5.85M5.85M6.62M8.33M11.93M12.72M
EBITDA Margin %
14.99%13.13%20.01%22.05%13.91%13.91%14.36%15.48%17.91%17.05%
EBITDA Growth %
191.32%-10.34%84.33%41.28%-23.84%0%13.16%25.9%43.14%6.48%
D&A (Non-Cash Add-back)
555K557K438K614K726K726K857K1.16M1.24M1.92M
EBIT
2.85M3.4M4.99M8.14M6.16M6.16M9.96M3.19M12.89M11.81M
Net Interest Income
15K218K48K-141K-226K-388K-239K-414K-747K-473K
Interest Income
27K225K268K95K126K76K294K144K82K95K
Interest Expense
12K7K220K236K352K464K533K558K829K367K
Other Income/Expense
15K218K449K836K571K571K3.67M-4.54M1.37M5.28M
Pretax Income
2.75M▲ 0%
2.61M▼ 5.2%
5.45M▲ 108.7%
7.9M▲ 45.1%
5.69M▼ 27.9%
5.69M▲ 0.0%
9.43M▲ 65.6%
2.63M▼ 72.1%
12.06M▲ 357.8%
16.09M▲ 0%
Pretax Margin %
12.54%11.62%20.05%22.68%13.54%13.54%20.46%4.89%18.11%21.56%
Income Tax
-2.09M989K1.3M1.79M1.12M1.12M2.35M507K3.08M4.09M
Effective Tax Rate %
-75.91%37.89%23.85%22.65%19.7%19.7%24.97%19.25%25.54%25.41%
Net Income
5.08M▲ 0%
1.62M▼ 68.1%
4.15M▲ 155.9%
6.11M▲ 47.3%
4.57M▼ 25.2%
4.57M▲ 0.0%
7.07M▲ 54.7%
2.13M▼ 69.9%
8.98M▲ 322.1%
12M▲ 0%
Net Margin %
23.17%7.22%15.27%17.55%10.88%10.88%15.35%3.95%13.48%16.08%
Net Income Growth %
518.49%-68.12%155.89%47.35%-25.2%0%54.72%-69.93%322.1%28.11%
Net Income (Continuing)
4.84M1.62M4.15M6.11M4.57M4.57M7.07M2.13M8.98M12M
Discontinued Operations
243K000000000
Minority Interest
0000000000
EPS (Diluted)
1.25▲ 0%
0.37▼ 70.4%
0.97▲ 162.2%
1.50▲ 54.6%
1.13▼ 24.7%
1.21▲ 7.1%
1.95▲ 61.2%
0.60▼ 69.2%
2.67▲ 345.0%
3.67▲ 0%
EPS Growth %
525%-70.4%162.16%54.64%-24.67%7.08%61.16%-69.23%345%29.29%
EPS (Basic)
1.260.380.991.561.171.261.980.612.73-
Diluted Shares Outstanding
4.08M4.34M4.3M4.08M3.94M3.76M3.64M3.57M3.36M3.27M
Basic Shares Outstanding
4.04M4.3M4.19M3.91M3.8M3.64M3.57M3.5M3.29M3.2M
Dividend Payout Ratio
--0.55%-------

PDEX Balance Sheet

Pro-Dex, Inc. (PDEX) balance sheet — assets, liabilities & shareholders' equity

MetricJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Total Current Assets
11.92M16.23M21.78M22.67M31.17M31.17M30.98M36.61M47.3M53.71M
Cash & Short-Term Investments
4.92M7.41M10.39M8.98M1.6M1.6M4.07M6.85M7.16M9.99M
Cash Only
4.21M5.19M7.74M6.42M849K849K2.94M2.63M419K9.99M
Short-Term Investments
718K2.22M2.65M2.56M755K755K1.13M4.22M6.74M0
Accounts Receivable
3.62M4.13M4.1M5.16M15.38M15.38M9.95M13.89M17.49M19.47M
Days Sales Outstanding
60.2867.1255.0854.02133.56133.5678.8294.1495.8689.8
Inventory
3.08M4.39M6.24M8.24M12.68M12.68M16.17M15.27M22.21M22.36M
Days Inventory Outstanding
76.3110.41130.94138.62160.07160.07177141.84172.2148.71
Other Current Assets
374K32K430K155K710K710K494K262K434K1.89M
Total Non-Current Assets
4.43M3.68M3.74M8.45M17.92M17.92M20.84M15.87M13.9M21.27M
Property, Plant & Equipment
1.43M1.75M2.73M5.63M13.42M13.42M13.2M12.65M1.05M716K
Fixed Asset Turnover
15.36x12.80x9.97x6.19x3.13x3.13x3.49x4.26x63.42x20.53x
Goodwill
112K000000006.53M
Intangible Assets
320K140K129K162K118K118K81K54K26K712K
Long-Term Investments
450K43K582K2.36M4.08M4.08M7.52M1.56M148K888K
Other Non-Current Assets
71K68K40K42K42K42K42K42K11.26M11.58M
Total Assets
16.35M▲ 0%
19.92M▲ 21.8%
25.52M▲ 28.1%
31.13M▲ 22.0%
49.09M▲ 57.7%
49.09M▲ 0.0%
51.82M▲ 5.6%
52.48M▲ 1.3%
61.19M▲ 16.6%
74.98M▲ 0%
Asset Turnover
1.34x1.13x1.06x1.12x0.86x0.86x0.89x1.03x1.09x1.14x
Asset Growth %
46.69%21.81%28.13%21.97%57.71%0%5.57%1.26%16.61%51.05%
Total Current Liabilities
2.58M2.54M4.27M5.23M11.35M11.35M9.68M12.89M14.63M14.64M
Accounts Payable
1.16M1.08M2M1.97M3.76M3.76M2.26M4.51M4.61M5.25M
Days Payables Outstanding
28.6727.2241.8933.0647.4947.4924.7541.9235.7730.36
Short-Term Debt
26K35K622K651K3.29M3.29M3.83M4.37M6.15M4.19M
Deferred Revenue (Current)
19K31K215K200K1.01M1.01M014K202K631K
Other Current Liabilities
528K807K0000001.63M5.05M
Current Ratio
4.62x6.40x5.10x4.34x2.74x2.74x3.20x2.84x3.23x3.67x
Quick Ratio
3.42x4.67x3.64x2.76x1.63x1.63x1.53x1.66x1.71x2.14x
Cash Conversion Cycle
107.92150.31144.12159.57246.15246.15231.07194.05232.29208.15
Total Non-Current Liabilities
61K103K4.24M6.84M12.3M12.3M10.56M8.72M9.93M15.14M
Long-Term Debt
06K3.93M3.28M10.25M10.25M8.91M7.54M9.25M15.14M
Capital Lease Obligations
61K6K02.75M2.05M2.05M1.64M1.18M685K1.66M
Deferred Tax Liabilities
758K476K614K0008K000
Other Non-Current Liabilities
091K308K804K000000
Total Liabilities
2.64M2.64M8.51M12.06M23.66M23.66M20.23M21.61M24.56M29.78M
Total Debt
119K41K4.56M7.02M15.97M15.97M14.79M13.55M16.58M19.33M
Net Debt
-4.09M-5.15M-3.19M602K15.12M15.12M11.86M10.92M16.16M9.34M
Debt / Equity
0.01x0.00x0.27x0.37x0.63x0.63x0.47x0.44x0.45x0.43x
Debt / EBITDA
0.04x0.01x0.84x0.91x2.73x2.73x2.23x1.63x1.39x1.52x
Net Debt / EBITDA
-1.24x-1.75x-0.59x0.08x2.58x2.58x1.79x1.31x1.35x0.73x
Interest Coverage
237.25x486.43x22.69x34.48x17.49x13.27x18.69x5.72x15.55x32.18x
Total Equity
13.71M▲ 0%
17.28M▲ 26.0%
17.01M▼ 1.6%
19.06M▲ 12.1%
25.43M▲ 33.4%
25.43M▲ 0.0%
31.59M▲ 24.2%
30.87M▼ 2.3%
36.63M▲ 18.7%
45.2M▲ 0%
Equity Growth %
54.44%26.01%-1.55%12.08%33.41%0%24.22%-2.29%18.68%112.05%
Book Value per Share
3.363.983.964.676.466.768.698.6410.9013.82
Total Shareholders' Equity
13.71M17.28M17.01M19.06M25.43M25.43M31.59M30.87M36.63M45.2M
Common Stock
17.7M19.84M15.81M12.75M7.68M7.68M6.77M3.92M704K0
Retained Earnings
-4.03M-2.41M1.74M7.9M17.75M17.75M24.82M26.95M35.93M45.2M
Treasury Stock
0000000000
Accumulated OCI
33K-153K-549K-1.59M000000
Minority Interest
0000000000

PDEX Cash Flow Statement

Pro-Dex, Inc. (PDEX) cash flow — operating, investing & free cash flow history

MetricJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Cash from Operations
3.23M3.1M3.33M5.9M-847K-847K5.46M6.2M-1.68M7.34M
Operating CF Margin %
14.74%13.78%12.24%16.93%-2.01%-2.01%11.85%11.51%-2.53%-
Operating CF Growth %
594.21%-4.3%7.43%77.3%-114.36%0%744.86%13.49%-127.13%208.11%
Net Income
5.08M1.62M4.15M6.11M4.57M4.57M7.07M2.13M8.98M12M
Depreciation & Amortization
555K557K438K573K726K726K857K1.16M1.24M1.3M
Stock-Based Compensation
3K194K37K286K1.27M1.27M766K605K555K665K
Deferred Taxes
-2.05M391K1.42M-22K-63K-63K264K-1.56M140K138K
Other Non-Cash Items
-234K1.03M-370K26K-820K-820K-3.9M4.09M-2.14M-6.09M
Working Capital Changes
-125K-694K-2.35M-1.08M-6.54M-6.54M396K-225K-10.45M-670K
Change in Receivables
-633K569K-1.13M-1.06M-4.45M-4.45M5.43M-3.94M-2.55M-2.81M
Change in Inventory
279K-1.31M-1.85M-2M-4.24M-4.24M-3.49M898K-6.94M1.95M
Change in Payables
518K-57K1.13M604K1.99M1.99M-1.15M2.44M179K-486K
Cash from Investing
-1.03M-4.12M-1.22M-3.24M-1.24M-1.24M-885K-2.23M-238K2.72M
Capital Expenditures
-638K-934K-1.4M-565K-1.64M-1.64M-974K-983K-1.25M-93K
CapEx % of Revenue
2.91%4.16%5.15%1.62%3.9%3.9%2.11%1.83%1.87%0.12%
Acquisitions
636K30K19K-978K000000
Investments
----------
Other Investing
-447K-320K1.23M998K-33K-33K00-304K-6.78M
Cash from Financing
-298K2M450K-3.98M-790K-790K-2.49M-4.27M-292K-11.23M
Debt Issued (Net)
-59K-78K4.51M-630K8.79M756K-809K-816K3.48M-8.41M
Equity Issued (Net)
-312K2.04M-4.08M-3.39M-5.44M-1.61M-1.55M-3.5M-3.46M-2.79M
Dividends Paid
00-23K0000000
Share Repurchases
-312K-220K-3.98M-3.39M-5.54M-1.61M-1.55M-3.5M-3.5M-2.88M
Other Financing
73K38K51K39K-4.14M60K-134K50K-305K-27K
Net Change in Cash
1.91M▲ 0%
983K▼ 48.6%
2.55M▲ 159.8%
-1.32M▼ 151.7%
-2.87M▼ 117.4%
-2.87M▲ 0.0%
2.09M▲ 172.7%
-305K▼ 114.6%
-2.21M▼ 625.2%
-1.16M▲ 0%
Free Cash Flow
2.6M▲ 0%
2.16M▼ 16.8%
1.93M▼ 10.8%
5.33M▲ 176.6%
-2.52M▼ 147.2%
-2.52M▲ 0.0%
4.49M▲ 278.2%
5.22M▲ 16.2%
-2.93M▼ 156.1%
7.07M▲ 0%
FCF Margin %
11.84%9.62%7.1%15.31%-5.99%-5.99%9.74%9.69%-4.4%9.47%
FCF Growth %
1882.44%-16.75%-10.82%176.56%-147.22%0%278.24%16.22%-156.13%504.06%
FCF per Share
0.640.500.451.31-0.64-0.671.231.46-0.872.16
FCF Conversion (FCF/Net Income)
0.64x1.91x0.80x0.96x-0.19x-0.19x0.77x2.91x-0.19x0.59x
Interest Paid
12K7K199K218K463K463K521K555K818K608K
Taxes Paid
217K401K320K683K1.56M1.56M1.66M1.89M4.46M1.11M

PDEX Key Ratios

Pro-Dex, Inc. (PDEX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
45.02%10.46%24.2%33.89%20.55%17.98%24.81%6.81%26.6%29.1%
Return on Invested Capital (ROIC)
25.19%16.49%28.89%31.65%12.76%9.48%10.29%12.62%16.95%15.61%
Gross Margin
32.75%35.36%35.99%37.73%31.24%31.24%27.66%27.02%29.3%27.78%
Net Margin
23.17%7.22%15.27%17.55%10.88%10.88%15.35%3.95%13.48%16.08%
Debt / Equity
0.01x0.00x0.27x0.37x0.63x0.63x0.47x0.44x0.45x0.43x
Interest Coverage
237.25x486.43x22.69x34.48x17.49x13.27x18.69x5.72x15.55x32.18x
FCF Conversion
0.64x1.91x0.80x0.96x-0.19x-0.19x0.77x2.91x-0.19x0.59x
Revenue Growth
8.86%2.38%20.95%28.2%20.69%0%9.62%16.83%23.68%16.39%
Related:PDEX Dividend History·PDEX Revenue History·PDEX Price History·PDEX P/E History·PDEX Financial Ratios·PDEX Institutional Holders

PDEX SEC Filings & Documents

Pro-Dex, Inc. (PDEX) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 30, 2026·SEC

Material company update

Mar 27, 2026·SEC

Material company update

Feb 12, 2026·SEC

10-K Annual Reports

3
FY 2025

Sep 4, 2025·SEC

FY 2024

Sep 5, 2024·SEC

FY 2023

Oct 13, 2023·SEC

10-Q Quarterly Reports

6
FY 2026

Apr 30, 2026·SEC

FY 2026

Jan 29, 2026·SEC

FY 2025

Oct 30, 2025·SEC

PDEX Frequently Asked Questions

Pro-Dex, Inc. (PDEX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Pro-Dex, Inc. (PDEX) reported $74.6M in revenue for fiscal year 2025. This represents a 259% increase from $20.8M in 1996.

Pro-Dex, Inc. (PDEX) grew revenue by 23.7% over the past year. This is strong growth.

Yes, Pro-Dex, Inc. (PDEX) is profitable, generating $12.0M in net income for fiscal year 2025 (13.5% net margin).

Dividend & Returns

Pro-Dex, Inc. (PDEX) has a return on equity (ROE) of 26.6%. This is excellent, indicating efficient use of shareholder capital.

Pro-Dex, Inc. (PDEX) generated $7.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in PDEX back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →

How much would $100/month in PDEX be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →